Genetic Association Reveals Protection against Recurrence of Clostridium difficile Infection with Bezlotoxumab Treatment

Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B, indicated to prevent recurrence of C. difficile infection (rCDI) in high-risk adults receiving antibacterial treatment for CDI. An exploratory genome-wide association study investigated whether human genetic variation...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:mSphere
Main Authors: Shen, Judong, Mehrotra, Devan V., Dorr, Mary Beth, Zeng, Zhen, Li, Junhua, Xu, Xun, Nickle, David, Holzinger, Emily R., Chhibber, Aparna, Wilcox, Mark H., Blanchard, Rebecca L., Shaw, Peter M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7203456/
https://ncbi.nlm.nih.gov/pubmed/32376702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mSphere.00232-20
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki